Stereotaxis makes electromedical systems and disposable devices that physicians use in interventional procedures. STXS reports earnings on Tue, Nov 10, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 27 | Citizens | Maintained | Buy | |
| Aug 12 | TD Cowen | Maintained | Buy | |
| Nov 5 | Roth Capital | Reinstated | Buy |
Whale Options Flow
90DNo whale options trades in STXS in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether STXS is in one of them and how their past STXS trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered STXS in an article yet. Here's the latest on the wider market.
About Stereotaxis
Stereotaxis is a medical technology company based in St. Louis, Missouri. It makes electromedical systems and disposable interventional devices that physicians use to perform medical procedures. Its main customers are hospitals and the physicians who practice in them. Its product lines include Niobe, Genesis RMN, and Odyssey, and it works with business partners and seeks regulatory approval for additional disposable devices.
- Headquarters
- St.Louis, MO